Uneek Mehra SEC EDGAR Filings (CIK 0001881504)

SEC EDGAR filings, ownership reports, and insider transactions for Uneek Mehra.

Business address
C/O Bridgebio Oncology Therapeutics, Inc, 256 E. Grand Avenue, Suite 104, South San Francisco, CA, 94080
Get insider transactions for this reporting owner
Uneek Mehra has filed 12 SEC EDGAR filings since 09 Sep 2021

Latest Filings

Recent SEC filings for Uneek Mehra including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 28 Aug 2025 26 Aug 2025 001-41955
3 Open 3 document View SEC filing for 3 3 18 Aug 2025 11 Aug 2025 001-41955
4 Open 4 document View SEC filing for 4 4 10 Mar 2025 06 Mar 2025 001-39782
4 Open 4 document View SEC filing for 4 4 13 Dec 2023 11 Dec 2023 001-39782
4 Open 4 document View SEC filing for 4 03 Oct 2023 01 Oct 2023 001-39782
3 Open 3 document View SEC filing for 3 FORM 3 26 Sep 2023 22 Sep 2023 001-39782
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 10 Mar 2023 10 Mar 2023 001-37929
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 20 Dec 2022 16 Dec 2022 001-37929
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 20 Sep 2022 16 Sep 2022 001-37929
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 19 Apr 2022 15 Apr 2022 001-37929
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 17 Sep 2021 15 Sep 2021 001-37929
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 09 Sep 2021 07 Sep 2021 001-37929

About this filer

Uneek Mehra files with the SEC under CIK 0001881504. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages